- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 5.23M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 3.58K sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 1.09K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$4.45M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$7.74M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $4.44M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $4.99M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $2.07M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $2.72M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$622K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $11.22M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.62M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $5.28M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.62M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.28M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $4.69M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $6.41M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.69M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $8.01M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$1.40 |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$11.46 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$1.40 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$11.46 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $2.32M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.92M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$5M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$12.43M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$3.33M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$7.48M |